Does not increase risk of treatment-emergent mania in depressed bipolar patients
During an 8-week trial of olanzapine and OFC in bipolar I depressed patients, OFC and olanzapine did not increase the risk of treatment-emergent mania.
GSK counterclaim:
Depression is consistently among the most frequently observed side effects with olanzapine maintenance treatment (Supporting data 3 and 4).